These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9640997)

  • 1. Efficacy studies of paroxetine in panic disorder.
    Lydiard RB; Steiner M; Burnham D; Gergel I
    Psychopharmacol Bull; 1998; 34(2):175-82. PubMed ID: 9640997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of panic disorder: focus on paroxetine.
    Pollack MH; Doyle AC
    Psychopharmacol Bull; 2003; 37 Suppl 1():53-63. PubMed ID: 14566201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodologies and outcomes from the sertraline multicenter flexible-dose trials.
    Rapaport MH; Wolkow RM; Clary CM
    Psychopharmacol Bull; 1998; 34(2):183-9. PubMed ID: 9640998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of paroxetine with clocapramine in panic disorder.
    Saito M; Miyaoka H
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):449. PubMed ID: 17610675
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders].
    Mosolov SN; Smulevich AB; Nuller IuL; Grigor'evskikh VS; Kostiukova EG; Kuzavkova MV; Koliutskaia EV; Andriushchenko AV; Zelenina EV; Kosinskiĭ VP; Kozlovskiĭ VL; Bykov SI; Pererva IG
    Ter Arkh; 2000; 72(10):16-23. PubMed ID: 11220870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical picture and treatment of panic disorder accompanied with generalized anxiety].
    Reznik AM; Arbuzov AL; Khurbatova IG
    Voen Med Zh; 2007 Jan; 328(1):38-43. PubMed ID: 17436713
    [No Abstract]   [Full Text] [Related]  

  • 8. Paroxetine in panic disorder: clinical management and long-term follow-up.
    Dannon PN; Lowengrub K; Iancu I; Kotler M
    Expert Rev Neurother; 2004 Mar; 4(2):191-8. PubMed ID: 15853560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term treatment of panic disorder.
    Davidson JR
    J Clin Psychiatry; 1998; 59 Suppl 8():17-21; discussion 22-3. PubMed ID: 9707158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study.
    Marchesi C; De Panfilis C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1240-5. PubMed ID: 16678956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine treatment of mood and anxiety disorders in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine in child and adolescent outpatients with panic disorder.
    Masi G; Toni C; Mucci M; Millepiedi S; Mata B; Perugi G
    J Child Adolesc Psychopharmacol; 2001; 11(2):151-7. PubMed ID: 11436954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.
    Schruers K; Griez E
    J Psychopharmacol; 2004 Dec; 18(4):553-8. PubMed ID: 15582922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot open-label study of nefazodone in panic disorder.
    Bystritsky A; Rosen R; Suri R; Vapnik T
    Depress Anxiety; 1999; 10(3):137-9. PubMed ID: 10604088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid cannabis use and panic disorder: short term and long term follow-up study.
    Dannon PN; Lowengrub K; Amiaz R; Grunhaus L; Kotler M
    Hum Psychopharmacol; 2004 Mar; 19(2):97-101. PubMed ID: 14994319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine treatment of generalized anxiety disorder.
    Sheehan DV; Mao CG
    Psychopharmacol Bull; 2003; 37 Suppl 1():64-75. PubMed ID: 14566202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-efficacy of individual and combined treatments for panic disorder.
    McHugh RK; Otto MW; Barlow DH; Gorman JM; Shear MK; Woods SW
    J Clin Psychiatry; 2007 Jul; 68(7):1038-44. PubMed ID: 17685740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants?
    Dusseldorp E; Spinhoven P; Bakker A; van Dyck R; van Balkom AJ
    Psychother Psychosom; 2007; 76(3):154-61. PubMed ID: 17426414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of the self-report version of the Panic Disorder Severity Scale in Korea.
    Lee EH; Kim JH; Yu BH
    Depress Anxiety; 2009; 26(8):E120-3. PubMed ID: 19373866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.